Recent studies indicate that acidic nanoparticles may enhance lysosomal degradation by decreasing lysosomal pH, thereby restoring lysosomal function in various PD models, including those with ATP13A2 and GBA mutations[89]. The gene discussed is GBA1; the disease is Parkinson disease.